On the stock market since 2017, it operates in the world of money and finance. It has 92 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
An average decline of 62% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $4.8M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 8 buys and 0 sells. Management buying with its own money is usually read as a good sign.
It pays out $1.66 per share each year — regular cash for whoever holds the stock.
A loss of $5.7M against $4.8M in annual sales. And on top of that, sales fell from the year before.
This stock swings about 2.7 times as much as the market average. Big rallies — and big drops — can both happen fast.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, AFHBL sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: AFHBL is a high-risk stock — not yet profitable, and its future rides on its product catching on.